Scientific Advisory Board
In partnership with SCI Sucks, Unite 2 Fight Paralysis formed a Scientific Advisory Board (SAB) in September of 2012 to provide input on a pilot program to provide cost-free SAB oversight to organizations funding spinal cord injury research. Our intent was to provide investors in the SCI community with peer-reviewed recommendations on where to direct critical funding and information on specific research interests. As of November 2017, our SAB has received $7.4M in grant requests. A total of $4M in funding was granted and $2.3M in funding is currently pending approval. To learn more about this program, email firstname.lastname@example.org.
Phillip G. Popovich, PhD, Chair – Dr. Popovich is a Professor in the Department of Neuroscience and Director of the Center for Brain and Spinal Cord Repair at Ohio State University. His laboratory is an interdisciplinary research group dedicated to studying the complexities of CNS injury, inflammation and tissue repair. Inflammation can have devastating consequences in the spinal cord, and the lab is striving to develop novel therapies that will manipulate or over-ride normal immune function. In addition, the Popovich lab performs replication work for the NIH. Replication is a core principle of the scientific method. To establish validity, the results of an experiment performed by one group of scientists must be evaluated by an independent group of scientists. The second group attempts to repeat the experiment of the first group, based on the original description. If the outcomes are similar, replication has been achieved and the first experiment is validated. Dr. Popovich’s work in the replication process brings a detail-oriented perspective to evaluating scientific projects.
Moses V. Chao, PhD – Dr. Chao is a Professor of Cell Biology, Physiology, and Neuroscience, and professor of Psychiatry at the New York University School of Medicine. He is the former President of the 42,000-member Society for Neuroscience (SFN), made up of the world’s leading brain and spinal cord scientists. Dr. Chao’s lab at the Skirball Institute of Biomolecular Medicine focuses on the study of molecular neurobiology and understanding the mechanisms that lead to a. the generation of neural cells and their targets, and b. the mechanisms that allow axons to project to their targets, form synapses, and signal to one another. Dr. Chao believes strongly in the necessity for more discovery science to solve the challenges of neurodegenerative disease and trauma. He brings a wealth of knowledge and experience in the field of neuroscience to our Advisory Board, and we appreciate his service.
Jean de Vellis, PhD – Dr. de Vellis is a Distinguished Professor in the Department of Neurobiology at the University of California, Los Angeles. His laboratory is interested in the genetic and epigenetic molecular mechanisms that fashion the progression of stem cells into the amazing cellular phenotypic diversity of the central nervous system. His research has helped to define at the molecular level the plasticity of brain cells and their potential for regeneration in neurodegenerative diseases. A main focus of his laboratory is on the development of oligodendrocytes, the myelin forming cells in the central nervous system and a key cell in brain iron homeostasis. In 2008 Dr. de Vellis received the Bernard Haber Award from the American Society of Neurochemistry, recognizing his outstanding leadership and contributions in the field of neurochemistry. We welcome his valuable input to our Scientific Advisory Board.
Keith Tansey, MD, PhD – Dr. Tansey earned his BS and MS in Biology and Biomechanics from Stanford University and his MD and PhD in Neuroscience from the University of Texas Southwestern Medical Center. He then completed his Residency in Neurology at Washington University in St. Louis and then Fellowships there and at the University of California at Los Angeles in Neurorehabilitation and Spinal Cord Injury Research. He was board certified in Neurology and then subspecialty board certified in Spinal Cord Injury Medicine and Neural Repair and Rehabilitation. Dr. Tansey serves on the Board of the American Society for Neurorehabilitation, and as a Board Officer for the American Spinal Injury Association and the International Society for Restorative Neurology. He is currently editing a book, “Neurological Aspects of Spinal Cord Injury” with two colleagues from Heidelberg, Germany. Dr. Tansey has grants to study neural plasticity after spinal cord injury in animal models and humans from the National Institutes of Disability and Rehabilitation Research, the Department of Defense, the Veterans Administration, and the Neilsen Foundation.
Steven Kirshblum, MD – Dr. Kirshblum is nationally recognized for his work in the area of spinal cord injury rehabilitation and research. He joined Kessler Institute in 1990 and currently serves as Medical Director of the West Orange campus, as well as the Director of the Spinal Cord Injury Program. Dr. Kirshblum received his medical degree from the University of Health Sciences/Chicago Medical School and completed a residency in physical medicine and rehabilitation at Mt. Sinai Hospital in New York City, where he was a chief resident. He became board certified in 1991 and was one of the first physicians in the country to receive special certification in spinal cord injury medicine in 1998. One of the most widely respected physicians in his field, Dr. Kirshblum has delivered more than 500 lectures nationally and internationally. He is the President of the Academy of Spinal Cord Injury Professionals, Chair of the International Standards Committee for the American Spinal Association and a member of numerous advisory boards and foundations for spinal cord research.
Brian Kwon, MD, PhD, FRCSC – Dr. Kwon is the Canada Research Chair in Spinal Cord Injury and a Professor in the Department of Orthopaedics at the University of British Columbia (UBC). As a surgeon-scientist, he is particularly interested in the bi-directional process of translational research for spinal cord injury – both “bench to bedside” and “bedside back to bench”. He has worked extensively on establishing biomarkers of human SCI to facilitate human trials and is leading a national biobanking effort in acute SCI. In his laboratory he has developed novel preclinical small and large animal models of SCI that can serve as the testing ground for therapeutic strategies and for conducting bedside back to bench translational studies. He has also led initiatives to establish a framework for how promising therapies for SCI should be evaluated in the laboratory setting prior to translation into human patients.
John Houle, PhD – Dr. Houle is a professor in the Department of Neurobiology & Anatomy at Drexel University College of Medicine, and director of the Spinal Cord Research Center. Prior to coming to Drexel, he taught at the University of Arkansas for Medical Sciences (UAMS), also serving as the director of the Division of Cellular and Molecular Neurobiology and the Neuroscience Research Core Facilty at UAMS. Dr. Houle has long been interested in neurotransplantation strategies to promote structural and functional recovery after spinal cord injury. Research in his laboratory is designed to examine multiple aspects of the neuronal and glial cell response to spinal cord injury, with the intent of designing a combinatorial treatment strategy for regeneration leading to functional recovery. Dr. Houle’s career has been a pursuit of understanding how the regenerative response of injured neurons is regulated, why some neuron groups are strong regenerators while others exhibit very limited regenerative effort, and how we might enhance regeneration in acute and chronic injury conditions.